Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 06-Feb-24 4:05 PM View:  | Prokidney Corp. (PROK) | 05-Feb-24 | Conversion | 748,952 | -- | -- | 100% 0 to 748.95K | |
| 06-Feb-24 4:05 PM View: | Prokidney Corp. (PROK) | 05-Feb-24 | Disposition (other) | 748,952 | -- | -- | (100%) 748.95K to 0 | |
| 16-Nov-23 5:50 PM View: | Royalty Pharma Plc (RPRX) | 16-Nov-23 | Disposition (other) | 383,000 | -- | -- | (9%) 4.04M to 3.66M | |
| 01-Nov-23 5:27 PM View: | Prokidney Corp. (PROK) | 30-Oct-23 | Conversion | 5,289,060 | -- | -- | 100% 0 to 5.29M | |
| 01-Nov-23 5:27 PM View: | Prokidney Corp. (PROK) | 30-Oct-23 | Disposition (other) | 5,289,060 | -- | -- | (100%) 5.29M to 0 | |
| 28-Jun-23 4:01 PM View: | Royalty Pharma Plc (RPRX) | 28-Jun-23 | Purchase | 130,000 | $29.51 | $3,836,770.00 | 4% 3.62M to 3.75M | |
| 13-Jun-23 4:01 PM View: | Royalty Pharma Plc (RPRX) | 13-Jun-23 | Purchase | 45,000 | $32.78 | $1,474,900.00 | 1% 3.57M to 3.62M | |
| 13-Jun-23 4:01 PM View: | Royalty Pharma Plc (RPRX) | 12-Jun-23 | Purchase | 45,000 | $33.00 | $1,484,950.00 | 1% 3.53M to 3.57M | |
| 24-May-23 6:45 PM View: | Royalty Pharma Plc (RPRX) | 24-May-23 | Purchase | 150,000 | $32.25 | $4,837,440.00 | 4% 3.38M to 3.53M | |
| 17-May-23 6:41 PM View: | Royalty Pharma Plc (RPRX) | 17-May-23 | Purchase | 69,612 | $32.94 | $2,293,100.00 | 2% 3.31M to 3.38M | |
| 17-May-23 6:41 PM View: | Royalty Pharma Plc (RPRX) | 16-May-23 | Purchase | 160,388 | $33.57 | $5,383,730.00 | 5% 3.15M to 3.31M | |
| 16-Nov-23 5:50 PM View: | Royalty Pharma Plc (RPRX) | 30-Dec-22 | Gift | 292,190 | -- | -- | 8% 3.75M to 4.04M | |
| 16-Aug-22 6:55 PM View: | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition (change in control) | 31,933,300 | -- | -- | (100%) 31.93M to 0 | |
| 15-Apr-22 6:55 PM View: | Royalty Pharma Plc (RPRX) | 14-Apr-22 | Disposition (other) | 462,031 | -- | -- | (10%) 4.42M to 3.96M | |
| 15-Apr-22 6:55 PM View: | Royalty Pharma Plc (RPRX) | 14-Apr-22 | Disposition (other) | 350,000 | -- | -- | (9%) 3.96M to 3.61M | |
| 01-Feb-22 4:17 PM View: | Epizyme, Inc. (EPZM) | 31-Jan-22 | Private Purchase | 22,666,700 | $1.50 | $34,000,000.00 | 247% 9.17M to 31.83M | |
| 11-May-21 9:03 PM View: | Royalty Pharma Plc (RPRX) | 07-May-21 | Conversion | 2,325,000 | -- | -- | 923% 251.81K to 2.58M | |
| 15-Apr-22 6:55 PM View: | Royalty Pharma Plc (RPRX) | 20-Oct-20 | Conversion | 428,420 | -- | -- | 11% 3.99M to 4.42M | |
| 22-Jun-20 9:55 PM View: | Royalty Pharma Plc (RPRX) | 18-Jun-20 | Conversion | 241,810 | -- | -- | (2418%) (-10.0K) to 231.81K | |
| 22-Jun-20 9:55 PM View: | Royalty Pharma Plc (RPRX) | 18-Jun-20 | Purchase | 20,000 | $28.00 | $560,000.00 | 9% 231.81K to 251.81K | |
| 15-Apr-22 6:55 PM View: | Royalty Pharma Plc (RPRX) | 16-Jun-20 | Conversion | 493,750 | -- | -- | 14% 3.5M to 3.99M | |
| 13-Feb-20 6:47 PM View: | Epizyme, Inc. (EPZM) | 11-Feb-20 | Grant | 2,500,000 | $20.00 | $50,000,000.00 | 38% 6.67M to 9.17M |